Tender for Child Health Clinical Outcome Review Programme
The contract is let initially to be delivered for NHS-funded care in England, Wales, Scotland and Northern Ireland for a period of 3 years.
United Kingdom-London: Health services
Section I: Contracting authority
I.1)Name and addresses
Dawson House, 5 Jewry Street
Contact person: Nicholas Holmes
NUTS code: UK
I.4)Type of the contracting authority
Section II: Object
HQIP NCA 2059 Child Health Clinical Outcome Review Programme
II.1.2)Main CPV code
II.1.3)Type of contract
The Child Health Clinical Outcome Review Programme was first commissioned by HQIP in 2015 and has been delivered to date by The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) team. The Child Health Clinical Outcome Review Programme is one of four Clinical Outcome Review Programmes (previously known as confidential enquiries) which are designed to help assess the quality of healthcare, and stimulate improvement in safety and effectiveness by systematically enabling clinicians, managers and policy makers to learn from adverse events and other relevant data. The Child Health Clinical Outcome and Review Programme is commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England, Welsh Government, the Scottish Government, the Northern Ireland Department of Health and the States of Jersey, Guernsey, and the Isle of Man. The successful bidder will build on the experiences and achievements of the programme since its inception.
II.1.5)Estimated total value
II.1.6)Information about lots
II.2.2)Additional CPV code(s)
II.2.3)Place of performance
II.2.4)Description of the procurement:
Full details of the Authority’s requirements are set out in the specification document.
Please follow the link to view the specification and to formally express your interest in this contract opportunity. Potential providers must complete the supplier registration form and declaration on the system and submit for approval before they can access the Invitation to Tender (ITT) which is a separate event.
NB: This is a one stage process and the deadline given for the submission of complete tenders is the same as expressions of interest.
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
There is potential to extend the contract for up to 2 additional years, subject to topic prioritisation by the funders, the availability of funding and an assessment by HQIP on the quality of the delivery of the programme.
II.2.10)Information about variants
II.2.11)Information about options
The contract is let initially to be delivered for NHS-funded care in England, Wales, Scotland and Northern Ireland for a period of 3 years, at a maximum total budget of up to 1 193 380 GBP excluding VAT and bids exceeding this limit may be rejected. In addition, the States of Jersey and Guernsey, and the Isle of Man, may join the programme at later date although this is yet to be confirmed. The additional contract value that would be offered to support the participation of the States of Jersey and Guernsey, and the Isle of Man would be 1 540 GBP per annum pro rata excl. VAT. If the States of Jersey and Guernsey, and the Isle of Man joined early in the first year and the whole contract was then extended to the 5 years’ total duration, subject to topic prioritisation by the funders, the availability of funding and an assessment by HQIP on the quality of the delivery of the programme, the maximum contract value would be 1 996 000 GBP excl. VAT. The contract is anticipated to start on 1.1.2020.
Potential future aspirational intent.
The future aspirational intention of this opportunity is to potentially include:
— different topics,
— combining NCAPOP projects/programmes,
— extending service coverage to include additional countries and/or devolved nations,
— extending service coverage to include non-NHS funded care,
— additional or enhanced delivery of any aspect of the Child Health Clinical Outcome Review Programme,
— other external quality improvement initiatives either related to or linked with the project.
Please note, there is no commitment by the Authority at this stage to include any of these. Taking this aspirational intent into account as well as the possibility that a contract extension may be offered for an additional 2 years, the potential ceiling value is 7 000 000 GBP excluding VAT.
NB: Bidders should submit their schedule of offer based on “core” delivery for the initial 3 years only. The maximum budget “core” value is 1 193 380 GBP excluding VAT. This excludes the aspirational intent elements listed above.
II.2.13)Information about European Union funds
HQIP uses an e-procurement system.
Section III: Legal, economic, financial and technical information
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
This procurement exercise will be conducted via the Authority’s e-tendering portal http://redirect.transaxions.com/events/UQmsa
There will be no hard copy documents issued to potential providers and all communications between potential providers and the Authority, including tender submissions will be through the e-tendering portal.
III.1.2)Economic and financial standing
As per the ITT.
III.1.3)Technical and professional ability
As per the ITT.
III.2.2)Contract performance conditions:
As per acceptance of HQIP standard terms and conditions of contract.
Any subsequent contract award will include a performance related pay element linked to the achievement of key contract deliverables which will be mutually agreed with the successful bidder.
Section IV: Procedure
IV.1.1)Type of procedure
IV.1.8)Information about the Government Procurement Agreement (GPA)
IV.2.2)Time limit for receipt of tenders or requests to participate
IV.2.4)Languages in which tenders or requests to participate may be submitted:
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders
HQIP uses an e-procurement system.
Section VI: Complementary information
VI.1)Information about recurrence
VI.2)Information about electronic workflows
The Authority delivers the National Clinical Audit and Patient outcome Programme (NCAPOP) on behalf of NHS England and the health departments of the UK devolved nations who wish to participate. Devolved nations are any body which has had powers relating to health services devolved to it by the Parliament of the United Kingdom, including but not limited to Scotland, Wales, Northern Ireland, Jersey, Guernsey and the Isle of Man.
The programme currently includes 40 specialty — specific national projects covering a range of medical, surgical and mental health conditions such as cancer, cardiac, dementia, diabetes and paediatric intensive care.
VI.5)Date of dispatch of this notice: